Navigation Links
PRA International Speaking Event: Beyond Global Feasibility
Date:3/19/2009

An Evidence-Based Approach to Creating Realistic Development Timelines

RALEIGH, N.C., March 19 /PRNewswire/ -- PRA International, a leading Clinical Research Organization, announces its Senior Vice President of Scientific and Medical Affairs, Kent Thoelke, will host a webinar on optimizing site and country selection. The webinar will take place on March 25, 2009 at 11:30 am ET.

Mr. Thoelke will discuss how to mitigate one of the greatest risks for successful drug development: delayed clinical development timelines. Detailed planning and appropriate site and country selection are the most critical factors in meeting target patient accrual goals within the planned timeline. Mr. Thoelke will explore how an evidence-based approach, coupled with survey based feasibility provides the most accurate forecast for patient accrual and the selection of sites and countries with the highest likelihood of being productive.

With PRA since 2006, Mr. Thoelke has over 19 years of experience in the global drug development and device industry, holding positions in both clinical and corporate development in multinational R&D companies, as well as small and emerging biotechnology companies. As part of the PRA Leadership Team, Mr. Thoelke provides high-level strategic oversight of product development, supporting PRA teams that are executing studies for Sponsors. Having visited over 40 countries, he is very familiar with the global drug development environment, and has established relationships with therapeutic experts in numerous indications around the world. Mr. Thoelke has spoken widely regarding the current landscape of clinical trial recruitment and its effect on drug development timelines. He is active in pursuing novel technologies and strategies to move the current clinical drug development paradigm away from anecdotal strategy to a more focused evidence-based strategy.

The deadline for registration is Tuesday March 24, 2009. Registration information can be found at: http://www.fxconferences.com/Beyond-Global-Feasibility-An-Evidence-Based-Approach-to-Creating-Realistic-Development-Timelines-P300.aspx .

About PRA International

PRA International is a global Clinical Research Organization providing services through all phases of clinical development. Although we specialize in Oncology, CNS, Respiratory/Allergy, Cardiovascular and Infectious Diseases, we perform studies in all therapeutic areas. PRA has supported over 2,100 clinical trials through its 35 global offices. PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge, enable our project teams to deliver consistent and on time performance for our clients.

To learn more about PRA International, please visit http://www.prainternational.com, email endpoints@praintl.com or call our Global Headquarters at +1 (919) 786-8200.


'/>"/>
SOURCE PRA International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Toxic Chemicals in Childrens Bath Products Trigger International Outcry
2. Barriers to diabetes care include restaurants and high-risk lifestyles, says international review
3. Valeant Pharmaceuticals Appoints President of Valeant Pharmaceuticals International
4. International Trachoma Initiative and the Task Force for Child Survival and Development Announce New Merger to Eliminate Blinding Trachoma and Fight Against Other Neglected Tropical Diseases
5. Mobile Massage Team Attending International Special Events Society Greater Philadelphia Chapter Industry Showcase - FRESH! 2009
6. Siemens to Donate Hearing Instruments Through Second Annual Partnership With Quota International
7. Relsys International Announces the Release of the Argus Safety(TM) Suite 5.0
8. DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008
9. Irish-Owned Heritage Casket Company Strikes Multi-Million-Dollar Partnership Deal With Pennsylvanias Matthews International
10. AJWS Asks International Community to Demand Reinstatement of International Aid Groups Into Sudan
11. Clinical Care Options and NAM Selected by the International AIDS Society to Collaborate on Official Online Conference Coverage From Annual Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2017)... ... August 19, 2017 , ... ... is the first organization with pending recognition status from the Centers for Disease ... via group telehealth classes and live video conferencing. , The DPP resulted ...
(Date:8/19/2017)... ... 19, 2017 , ... Parker at Stonegate, an assisted living ... employees, caregivers, volunteers, thought leaders, researchers, educators and partners leading the way in ... to refresh the carpeting with the goal of maintaining the same precise colors ...
(Date:8/18/2017)... VA (PRWEB) , ... August 18, 2017 , ... More ... the Democratic Republic of Congo (DRC) thanks to an ambitious venture that conjoined the ... well as the generous support of the Liberty community. These shoes will save lives ...
(Date:8/18/2017)... NY (PRWEB) , ... August 18, 2017 , ... ... of this summer’s edition of “Vision & Hearing,” advocating for active, healthy lifestyles ... focuses on resources available for individuals with hearing impairments and shares the latest ...
(Date:8/18/2017)... ... August 18, 2017 , ... Hernandez Insurance Agencies, a northern ... the greater DC region, is inaugurating a “New Leash On Life” charity initiative ... training them to be companions for veterans in need. , The Semper K9 ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... OCEANSIDE, Calif. , Aug. 15, 2017  AOTI Inc. announced ... Advanced Oxygen Therapy Inc., has recently opened a New York City ... the ever-increasing usage of its unique Topical Wound Oxygen (TWO 2 ... approved by the Accreditation Commission for Health Care (ACHC) under the ... ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) today ... effective Aug. 7, 2017. ... interests and will serve as president emeritus during a planned, ... in multiple leadership roles since he joined Diplomat with the ... provided decisive, strategic leadership which continues to benefit our patients ...
Breaking Medicine Technology: